Percutaneous coronary intervention with oral sirolimus and bare metal stents has comparable safety and efficacy to treatment with drug eluting stents, but with significant cost saving: long-term follow-up results from the randomised, controlled ORAR III (Oral Rapamycin in ARgentina) study. [electronic resource]
Producer: 20100812Description: 255-64 p. digitalISSN:- 1969-6213
- Administration, Oral
- Aged
- Angioplasty, Balloon, Coronary -- adverse effects
- Argentina
- Cardiovascular Agents -- administration & dosage
- Coronary Angiography
- Coronary Artery Disease -- diagnostic imaging
- Coronary Restenosis -- diagnostic imaging
- Cost Savings
- Drug-Eluting Stents
- Female
- Health Care Costs
- Hospital Mortality
- Humans
- Kaplan-Meier Estimate
- Logistic Models
- Male
- Metals
- Middle Aged
- Myocardial Infarction -- etiology
- Proportional Hazards Models
- Prospective Studies
- Prosthesis Design
- Risk Assessment
- Sirolimus -- administration & dosage
- Stents
- Stroke -- etiology
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.